IP Library › Granted Patent US 11,806,526
Granted Patent B2
US 11,806,526 · App. 17/012,481 · Granted Nov 7, 2023

Stimulation for treating sleep disordered breathing

Inventors: Darrell Wagner (Ham Lake, MN); Quan Ni (Shoreview, MN); John Rondoni (Plymouth, MN); Dave Dieken (Minneapolis, MN)
Assignee: INSPIRE MEDICAL SYSTEMS, INC.
A61N1/3601A61B5/0816A61B5/0826A61B5/113A61B5/4818A61B5/4848A61B5/686A61N1/3611G16H20/40A61B5/0205A61N1/3614A61N1/36146A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,806,526
App. No.
17/012,481
Granted
Nov 7, 2023
Kind
B2
Abstract

A device for treating sleep disordered breathing includes a stimulation element to stimulate an airway-patency-related nerve.

Claims (27)

1. A device for treating obstructive sleep apnea, comprising: a non-cardiac stimulation means for stimulating an upper airway patency-related nerve, wherein, the non-cardiac stimulation element comprises an implantable electrode and/or an implantable pulse generator electrically connectable to the implantable electrode according to a first stimulation therapy protocol including alternating stimulation periods and non-stimulation periods in which a timing of the stimulation periods is asynchronous relative to patient breathing, wherein a duration of each respective stimulation period is greater than a duration of each respective non-stimulation period, and wherein the duration of each respective stimulation period is based on a reference respiratory-related parameter.

2. The device of claim 1 , wherein the asynchronous timing of the stimulation relative to patient breathing comprises the timing being not based on actively-sensed respiration during application of the first stimulation therapy protocol.

3. The device of claim 1 , wherein the reference respiratory-related parameter comprises a reference respiratory pattern.

4. The device of claim 3 , wherein the reference respiratory pattern comprises a reference respiratory cycle, and wherein a duration of each respective stimulation period is greater than a duration of an inspiratory phase of the reference respiratory cycle.

5. The device of claim 1 , wherein the reference respiratory-related parameter is based on stable respiration.

6. The device of claim 1 , wherein the reference respiratory-related parameter comprises a reference respiratory cycle and wherein a combined duration of a respective one of the stimulation periods and a respective one of the non-stimulation periods is less than a duration of the reference respiratory cycle.

7. The device of claim 1 , wherein the reference respiratory-related parameter comprises a reference respiratory cycle and wherein the combined duration of a respective one of the stimulation periods and of a respective one of the non-stimulation periods is no greater than a duration of a reference respiratory cycle.

8. The device of claim 1 , wherein the duration of the respective stimulation periods remain uniform.

9. The device of claim 1 , wherein the reference respiratory-related parameter comprises a reference respiratory cycle, and wherein the combined duration of a respective one of the stimulation periods and of a respective one of the non-stimulation periods is less than 30 percent of duration of a reference respiratory cycle.

10. The device of claim 1 , wherein a respective one of the stimulation periods and a respective one of the non-stimulation periods are in a proportion of at least 1.5 to 1.

11. The device of claim 10 , wherein a duration of a respective one of the stimulation periods exceeds the duration of a respective one of the non-stimulation periods by a factor of 3.

12. The device of claim 1 , wherein a combination of a respective one of the stimulation periods and a respective one of the non-stimulation periods comprises a stimulation cycle, and wherein a duration of the respective one of the stimulation periods comprises at least 80 percent of a duration of the stimulation cycle.

13. The device of claim 1 , wherein each respective stimulation period comprises continuous pulsed stimulation.

14. The device of claim 1 , comprising:

a processor; and

a non-volatile computer readable medium storing instructions, executable on the processor, to implement the first stimulation protocol.

15. The device of claim 1 , wherein the first stimulation therapy protocol is to be applied during a treatment period in which the patient is to engage in sleeping behavior.

16. A device for treating obstructive sleep apnea, comprising: a non-cardiac means for stimulating an upper airway patency-related nerve wherein, the non-cardiac stimulation element comprises an implantable electrode and/or an implantable pulse generator electrically connectable to the implantable electrode, according to a first stimulation therapy protocol including alternating stimulation periods and non-stimulation periods in which a timing of the stimulation periods is asynchronous relative to patient breathing, wherein a duration of each respective stimulation period is greater than a duration of each respective non-stimulation period, wherein each stimulation period comprises continuous pulsed stimulation, wherein the first stimulation protocol is to deliver multiple stimulation periods within a duration of a reference respiratory cycle.

17. The device of claim 16 , wherein the duration of each respective non-stimulation period is at least less than half of the duration of each respective stimulation period.

18. The device of claim 16 , wherein the reference respiratory cycle comprises at least one of:

a historical patient-specific reference respiratory cycle; and

a multiple patient reference respiratory cycle.

19. The device of claim 16 , wherein the first stimulation therapy protocol is to deliver at least some of the multiple stimulation periods within a duration of an inspiratory phase of the reference respiratory cycle.

20. The device of claim 16 , wherein the duration of each respective stimulation period is at least less than 30 percent of a duration of the reference respiratory cycle.

21. The device of claim 16 , wherein a combination of a respective one of the stimulation periods and a respective one of the non-stimulation periods comprises a stimulation cycle, and wherein the first stimulation therapy protocol is to deliver more than one stimulation cycle within a duration of the reference respiratory cycle.

22. A device for treating obstructive sleep apnea, comprising: a non-cardiac means for stimulating an upper airway patency-related nerve, wherein, the non-cardiac stimulation element comprises an implantable electrode and/or an implantable pulse generator electrically connectable to the implantable electrode, according to a first stimulation therapy protocol including alternating stimulation periods and non-stimulation periods in which a timing of the stimulation periods is asynchronous relative to patient breathing, wherein a duration of each respective stimulation period is greater than a duration of each respective non-stimulation period, and wherein a combined duration of a respective one of the stimulation periods and a respective one of the non-stimulation periods is greater than a duration of a reference respiratory cycle.

23. The device of claim 22 , wherein the duration of a respective one of the stimulation periods is greater than the duration of the reference respiratory cycle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2021
From: WAGNER, DARRELL; NI, QUAN; RONDONI, JOHN; DIEKEN, DAVID
To: INSPIRE MEDICAL SYSTEMS, INC.
Reel/Frame 057876/0698 →
Continuity (3)
Continuation 15562714
Provisional Application 62135305 · Mar 19, 2015
Related Publication 20200398051A1 · Dec 24, 2020